EUVIMEDEUVIMED entdecken
Crossref

Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations

Shruti Gupta, Shveta S Motwani, Robert H Seitter, Wei Wang, Yi Mu, Donald F Chute, Meghan E Sise, Daniel I Glazer, Bernard A Rosner, Gary C Curhan

American Journal of Roentgenology · 2023

DOI: 10.2214/ajr.23.29139 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Roentgenology, 2023. Verfasst von Shruti Gupta und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Renal Medicine, Brigham and Women's Hospital, 75 Francis St, MRB-4, Boston, MA 02115. Hauptthemen laut MEDLINE: Acute Kidney Injury, Renal Insufficiency, Chronic, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND. Patients with cancer undergo frequent CT examinations with iodinated contrast media and may be uniquely predisposed to contrast-associated acute kidney injury (CA-AKI). OBJECTIVE. The purpose of this study was to develop and validate a model for predicting the risk of CA-AKI after contrast-enhanced CT in patients with cancer. METHODS. This retrospective study included 25,184 adult patients (12,153 men, 13,031 women; mean age, 62.3 ± 13.7 [SD] years) with cancer who underwent 46,593 contrast-enhanced CT examinations between January 1, 2016, and June 20, 2020, at one of three academic medical centers. Information was recorded regarding demographics, malignancy type, medication use, baseline laboratory values, and comorbid conditions. CA-AKI was defined as a 0.3-mg/dL or greater increase in serum creatinine level from baseline within 48 hours after CT or a 1.5-fold or greater increase in the peak measurement within 14 days after CT. Multivariable models accounting for correlated data were used to identify risk factors for CA-AKI. A risk score for predicting CA-AKI was generated in a development set (n = 30,926) and tested in a validation set (n = 15,667). RESULTS. CA-AKI occurred after 5.8% (2682/46,593) of CT examinations. The final multivariable model for predicting CA-AKI included hematologic malignancy, diuretic use, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use, chronic kidney disease (CKD) stage 3a, CKD stage 3b, CKD stage 4 or 5, serum albumin level less than 3.0 g/dL, platelet count less than 150 × 103/μL, 1+ or greater proteinuria on baseline urinalysis, diabetes mellitus, heart failure, and contrast medium volume 100 mL or greater. A risk score (range, 0-53 points) was generated with these variables. The most points (13) were for CKD stage 4 or 5 and for albumin level less than 3 g/dL. The frequency of CA-AKI progressively increased in higher risk categories. For example, in the validation set, CA-AKI occurred after 2.2% of CT examinations in the lowest risk category (score ≤ 4) and after 32.7% of CT examinations in the highest risk category (score ≥ 30). The Hosmer-Lemeshow test result indicated that the risk score was a good fit (p = .40). CONCLUSION. A risk model in which readily available clinical data are used to predict the likelihood of CA-AKI after contrast-enhanced CT in patients with cancer was developed and validated. CLINICAL IMPACT. The model may help facilitate appropriate implementation of preventive measures in the care of patients at high risk of CA-AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryRenal Insufficiency, ChronicNeoplasmsMaleAdultHumansFemaleMiddle AgedAgedRetrospective StudiesContrast MediaRisk FactorsTomography, X-Ray Computed

Stichwörter der Autor:innen

CTacute kidney injurycancercontrast mediummalignancy

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Division of Renal Medicine, Brigham and Women's Hospital, 75 Francis St, MRB-4, Boston, MA 02115.
  • Dana-Farber Cancer Institute, Boston, MA.
  • Lahey Hospital and Medical Center, Burlington, MA.
  • Departments of Medicine and Neurology, Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Boston, MA.
  • Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA.

Zitieren

APA

Gupta, S., Motwani, S. S., Seitter, R. H., Wang, W., Mu, Y., Chute, D. F., Sise, M. E., Glazer, D. I., Rosner, B. A., & Curhan, G. C. (2023). Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations. American Journal of Roentgenology. https://doi.org/10.2214/ajr.23.29139

Vancouver

Gupta S, Motwani SS, Seitter RH, Wang W, Mu Y, Chute DF, et al. Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations. American Journal of Roentgenology. 2023. doi:10.2214/ajr.23.29139

BibTeX
@article{Gupta2023,
  author = {Gupta, Shruti and Motwani, Shveta S and Seitter, Robert H and Wang, Wei and Mu, Yi and Chute, Donald F and Sise, Meghan E and Glazer, Daniel I and Rosner, Bernard A and Curhan, Gary C},
  title = {Development and Validation of a Risk Model for Predicting Contrast-Associated Acute Kidney Injury in Patients With Cancer: Evaluation in Over 46,000 CT Examinations},
  journal = {American Journal of Roentgenology},
  year = {2023},
  doi = {10.2214/ajr.23.29139}
}
Kostenlos starten →